当前位置: X-MOL 学术Mol. Cancer Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Highlights of This Issue
Molecular Cancer Therapeutics ( IF 5.7 ) Pub Date : 2018-01-01 00:00:00
American Association for Cancer Research

### [Couts et al. Page 222][1] Anaplastic lymphoma kinase (ALK) is an oncogenic kinase which can be expressed and activated in cancers by gene fusions. ALK fusions have not been identified in cutaneous melanomas, but expression of an alternate isoform of ALK (ALKATI) was reported as a potential

中文翻译:

本期要点

### [Couts等。Page 222] [1]间变性淋巴瘤激酶(ALK)是一种致癌激酶,可通过基因融合在癌症中表达和激活。尚未在皮肤黑色素瘤中鉴定出ALK融合蛋白,但据报道有可能表达ALK的另一种同工型(ALKATI)
更新日期:2018-01-02
down
wechat
bug